You have 9 free searches left this month | for more free features.

advanced solid cancers

Showing 1 - 25 of >10,000

STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS

Solid Tumor, Adult Trial in Beijing (Vaccine)

Not yet recruiting
  • Solid Tumor, Adult
  • Beijing, Beijing, China
    Peking Union Medical College Hospital
Aug 3, 2023

Metastatic Cancer, HER2 Gene Mutation Trial in Seoul (Neratinib Maleate)

Active, not recruiting
  • Metastatic Cancer
  • HER2 Gene Mutation
  • Neratinib Maleate
  • Seoul, Korea, Republic of
    Korea university Guro hospital
Oct 18, 2023

Solid Tumor Trial in Adelaide (Radvax)

Recruiting
  • Solid Tumor
  • Radvax
  • Adelaide, South Australia, Australia
    ARASMI
Apr 8, 2023

Solid Carcinoma Trial (fecal microbiota transplantation with Nivolumab)

Not yet recruiting
  • Solid Carcinoma
  • fecal microbiota transplantation with Nivolumab
  • (no location specified)
Sep 14, 2022

Advanced Solid Cancers Trial in Tainan (ADI PEG20, Pembrolizumab)

Terminated
  • Advanced Solid Cancers
  • Tainan, Taiwan
    Facility National Cheng Kung University
Apr 20, 2022

Advanced Solid Tumor, Triple Negative Breast Cancer Trial (Pembrolizumab & ADG106 (Phase Ib), Pembrolizumab & ADG106 (Phase II))

Not yet recruiting
  • Advanced Solid Tumor
  • Triple Negative Breast Cancer
  • Pembrolizumab & ADG106 (Phase Ib)
  • Pembrolizumab & ADG106 (Phase II)
  • (no location specified)
Aug 5, 2022

Locally Advanced Malignant Solid Tumor Trial in Houston (Pembrolizumab)

Recruiting
  • Locally Advanced Malignant Solid Neoplasm
  • Pembrolizumab
  • Houston, Texas
    M D Anderson Cancer Center
Mar 22, 2022

Tumor Trial in Chuo-Ku, Kashiwa (JNJ-63723283, Erdafitinib)

Completed
  • Neoplasm
  • Chuo-Ku, Japan
  • +1 more
Nov 3, 2022

Advanced Malignant Solid Tumor, Metastatic Malignant Solid Tumor Trial (Biopsy, Biospecimen Collection, Computed Tomography)

Not yet recruiting
  • Advanced Malignant Solid Neoplasm
  • Metastatic Malignant Solid Neoplasm
  • Biopsy
  • +3 more
  • (no location specified)
Jan 18, 2023

Gastric Cancer, Colorectal Cancer, Pancreatic Cancer Trial in Pittsburgh (Tumor Infiltrating Lymphocytes (TIL), Fludarabine +

Recruiting
  • Gastric Cancer
  • +9 more
  • Tumor Infiltrating Lymphocytes (TIL)
  • Fludarabine + Cyclophosphamide combination
  • Pittsburgh, Pennsylvania
    UPMC Hillman Cancer Center
Jul 21, 2022

Advanced Solid Tumor, NSCLCs Trial in Houston (Adagrasib, Olaparib)

Not yet recruiting
  • Advanced Solid Tumor
  • Non-small Cell Lung Cancers
  • Houston, Texas
    M D Anderson Cancer Center
Nov 15, 2023

Advanced Solid Tumor Trial (NXP900)

Not yet recruiting
  • Advanced Solid Tumor
  • (no location specified)
May 15, 2023

Cancers Trial in Nashville, Houston (NM6603)

Recruiting
  • Cancers
  • Nashville, Tennessee
  • +1 more
Sep 13, 2023

Advanced Cholangiocarcinoma, Advanced Hepatocellular Carcinoma, Advanced Malignant Solid Tumor Trial in Los Angeles (Biospecimen

Recruiting
  • Advanced Cholangiocarcinoma
  • +6 more
  • Biospecimen Collection
  • +3 more
  • Los Angeles, California
  • +1 more
Mar 31, 2023

Advanced Solid Cancers Trial in Canada, United States (BMS-986301, Nivolumab, Ipilimumab)

Recruiting
  • Advanced Solid Cancers
  • Chicago, Illinois
  • +4 more
Oct 1, 2021

Advanced Malignant Solid Tumor, Metastatic Malignant Solid Tumor, Recurrent Malignant Solid Tumor Trial in Houston (Laboratory

Completed
  • Advanced Malignant Solid Neoplasm
  • +3 more
  • Laboratory Biomarker Analysis
  • +3 more
  • Houston, Texas
    M D Anderson Cancer Center
Dec 21, 2022

Advanced Malignant Tumor, ALK Fusion Protein Expression, ALK Gene Amplification Trial in Columbus (Brigatinib, Laboratory

Withdrawn
  • Advanced Malignant Neoplasm
  • +10 more
  • Columbus, Ohio
    Ohio State University Comprehensive Cancer Center
Feb 15, 2022

Breast Cancer, Lung Cancer, Colorectal Cancer Trial in Kobe (e-PRO monitoring)

Enrolling by invitation
  • Breast Cancer
  • +7 more
  • e-PRO monitoring
  • Kobe, Hyogo, Japan
    Kobe University Graduate School
Jun 27, 2023

Tumors Trial in Worldwide (BI 765179, Ezabenlimab)

Recruiting
  • Neoplasms
  • Tucson, Arizona
  • +6 more
Aug 23, 2022

SCLC, Small Cell Cancer, Advanced Solid Tumor Trial run by the NCI (Lurbinectedin, Berzosertib)

Recruiting
  • SCLC
  • +3 more
  • Bethesda, Maryland
    National Institutes of Health Clinical Center
Jan 20, 2023

Advanced Solid Tumor, Metastatic Solid Tumor, NSCLCs Trial (PRT3789)

Recruiting
  • Advanced Solid Tumor
  • +3 more
  • Fairfax, Virginia
    NEXT Virginia
Feb 1, 2023

AXIN1 Gene Mutation, APC Gene Mutation, Solid Tumor Trial (REC-4881)

Not yet recruiting
  • AXIN1 Gene Mutation
  • +2 more
  • (no location specified)
Aug 21, 2023

Hepatocellular Carcinoma, Pancreatic Ductal Adenocarcinoma, Biliary Tract Cancers Trial (ABBV-400)

Not yet recruiting
  • Hepatocellular Carcinoma
  • +6 more
  • (no location specified)
Oct 10, 2023

Advanced Malignant Solid Tumor, Metastatic Malignant Solid Tumor, Refractory Malignant Solid Tumor Trial in Canada, United

Recruiting
  • Advanced Malignant Solid Neoplasm
  • +2 more
  • Biopsy
  • +6 more
  • Boston, Massachusetts
  • +5 more
Jan 7, 2023

Locally Advanced Malignant Solid Tumor, Metastatic Malignant Solid Tumor, Unresectable Malignant Solid Tumor Trial in Houston

Terminated
  • Locally Advanced Malignant Solid Neoplasm
  • +2 more
  • Houston, Texas
    M D Anderson Cancer Center
Dec 22, 2022